Phenomix Sciences is a precision medicine obesity biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavioral factors can inform obesity treatment plans. Mayo Clinic physicians, scientists, and researchers, Drs. Acosta and Camilleri, founded the company under the belief that the key to understanding obesity is unprecedented access to its clinical and molecular information throughout all stages and phenotypes of the disease.  Phenomix leverages data intelligence to yield better accuracy in predicting individual patient response to specific weight loss interventions and reducing the variability in weight loss results for patients. 

Securian Financial Group

Phenomix Sciences

Adiposs is a competitor of Phenomix Sciences in the precision health industry, focusing on metabolic health analysis and personalized health insights.

Adiposs

FibroScan competes with Phenomix Sciences in the field of metabolic health analysis and personalized health insights, utilizing advanced metabolic phenotyping.

FibroScan

Bellus Health is a competitor of Phenomix Sciences in the precision health industry, offering personalized health insights and metabolic health analysis.

Bellus Health

Adhezion Biomedical competes with Phenomix Sciences in the field of metabolic health analysis and personalized health insights, leveraging advanced metabolic phenotyping.

Adhezion Biomedical

Regentis Biomaterials is a competitor of Phenomix Sciences in the precision health industry, focusing on metabolic health analysis and personalized health insights.

Regentis Biomaterials

Adamas Pharmaceuticals competes with Phenomix Sciences in the field of metabolic health analysis and personalized health insights, utilizing advanced metabolic phenotyping.

Adamas Pharmaceuticals

Biovertis is a competitor of Phenomix Sciences in the precision health industry, offering personalized health insights and metabolic health analysis.

Biovertis

Kriya Therapeutics competes with Phenomix Sciences in the field of metabolic health analysis and personalized health insights, leveraging advanced metabolic phenotyping.

Kriya Therapeutics

Semma Therapeutics is a competitor of Phenomix Sciences in the precision health industry, focusing on metabolic health analysis and personalized health insights.

Semma Therapeutics

Phenomix Sciences is a precision health company that leverages advanced metabolic phenotyping to provide personalized health insights. The company's technology platform is designed to analyze individuals' metabolic data to inform tailored nutrition and health interventions.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 8:25 AM	7a6a8972
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 4:45 PM	57027443
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 22, 2024 8:25 AM	3c61ddf9
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 8:25 AM	d77e585a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PHENOMIXSCIENCES

Phenomix Sciences